Efficacy and Safety of Ischemic Preconditioning Therapy Versus Optimal Medical Therapy in Reducing the Recurrence of Ischemic Events in Symptomatic Moyamoya Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 256 participants.
Also called NCT07889531
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 256 participants
- Sponsor
- Registry
-
NCT07889531
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07889531. Randomized; quadruple masking; primary purpose prevention. Start 2026-10-10 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Ischemic Preconditioning Therapy Versus Optimal Medical Therapy in Reducing the Recurrence of Ischemic Events in Symptomatic Moyamoya Disease
- Condition
- Moya Moya Disease
- Condition
- Moyamoya Syndrome
- Intervention (Device)
- Standard Remote Ischemic Preconditioning
- Intervention (Device)
- Sham Remote Ischemic Preconditioning
- Lead sponsor
- Beijing Tiantan Hospital
- Collaborator
- Henan Provincial People's Hospital
- Collaborator
- The Fifth Medical Center of the PLA General Hospital
- Collaborator
- The First Affiliated Hospital of Zhengzhou University
- Collaborator
- The First Affiliated Hospital of Nanchang University
Record details
- Record id
cardio:ct-nct07889531- Content hash
52108bf60e2607dd36ba6d28f58e8be3c79f39fe3d97ebd6d4b21d697d80e735